Personnel Information

写真a

SEIRIKI Kaoru


Job title

Associate Professor
To the head of this page.▲

Graduating School 【 display / non-display 】

  • Osaka University, Graduate School of Pharmaceutical Sciences, 2017.03, Graduated

To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2025.10
    -
    Now
    Institute of Science Tokyo， -， Institute of Integrated Research， Advanced Pathophysiological Science， -， Associate Professor
To the head of this page.▲

External Career 【 display / non-display 】

  • 2017.04
    -
    2018.07
    Osaka University, Institute for Academic Initiatives , Project Assistant Professor
  • 2017.04
    -
    2022.03
    Osaka University, Graduate School of Pharmaceutical Sciences,
  • 2018.08
    -
    2022.03
    Osaka University, Project Assistant Professor
  • 2022.04
    -
    2023.08
    Osaka University, Graduate School of Pharmaceutical Sciences, Project Assistant Professor
  • 2023.09
    -
    2025.09
    Osaka University, Graduate School of Pharmaceutical Sciences, Assistant Professor
  • 2023.10
    -
    Now
    Japan Science and Technology Agency, PRESTO,
  • 2025.10
    -
    Now
    Institute of Science Tokyo, Institute of Integrated Research, Medical Research Laboratory, Associate Professor

▼display all

To the head of this page.▲

Academic Society Affiliations 【 display / non-display 】

  • THE JAPANESE PHARMACOLOGICAL SOCIETY

  • THE PHARMACEUTICAL SOCIETY OF JAPAN

  • THE JAPAN NEUROSCIENCE SOCIETY

  • THE JAPANESE SOCIETY FOR NEUROCHEMISTRY

  • Society for Neuroscience

To the head of this page.▲

Research Areas 【 display / non-display 】

  • Cognitive and brain science

  • Pharmaceutical hygiene and biochemistry

  • Pharmacology

  • Neuroscience-general

To the head of this page.▲
 

Research Theme 【 display / non-display 】

  • Development of whole-brain imaging system for spatial and temporal activation mapping, 2018.06 - 2020.03

To the head of this page.▲

Published Papers & Misc 【 display / non-display 】

  1. Volumetric trans-scale imaging of massive quantity of heterogeneous cell populations in centimeter-wide tissue and embryo. 2025.02; 13 ( PubMed, DOI )

  2. (R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice. 2024.02; ( PubMed, DOI )

  3. Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice. 2024.02; 154 (2): 72-76. ( PubMed, DOI )

  4. Clozapine Induces Neuronal Activation in the Medial Prefrontal Cortex in a Projection Target-Biased Manner. 2024; 47 (2): 478-485. ( PubMed, DOI )

  5. Correction to: Oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome. 2022.04; 15 (1): 34. ( PubMed, DOI )

  6. Claustrum mediates bidirectional and reversible control of stress-induced anxiety responses. 2022.03; 8 (11): eabi6375. ( PubMed, DOI )

  7. Oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome. 2022.03; 15 (1): 26. ( PubMed, DOI )

  8. Multiple alterations in glutamatergic transmission and dopamine D2 receptor splicing in induced pluripotent stem cell-derived neurons from patients with familial schizophrenia. 2021.10; 11 (1): 548. ( PubMed, DOI )

  9. Exploring rare cellular activity in more than one million cells by a transscale scope 2021.08; 11 (1): ( DOI )

  10. Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZWT/Q1038R mouse model of autism spectrum disorder. 2021.03; 14 (1): 56. ( PubMed, DOI )

  11. Altered Functional Connectivity of the Orbital Cortex and Striatum Associated with Catalepsy Induced by Dopamine D1 and D2 Antagonists. 2021; 44 (3): 442-447. ( PubMed, DOI )

  12. Direct visualization of an antidepressant analog using surface-enhanced Raman scattering in the brain 2020.03; 5 (6): ( PubMed, DOI )

  13. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression. 2020.02; 191 172876. ( PubMed, DOI )

  14. Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes. 2020.02; 11 (1): 859. ( PubMed, DOI )

  15. Autism-associated protein kinase D2 regulates embryonic cortical neuron development. 2019.11; 519 (3): 626-632. ( PubMed, DOI )

  16. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome. 2019.11; 44 (12): 2125-2135. ( PubMed, DOI )

  17. (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism. 2019.10; 22 (10): 665-674. ( PubMed, DOI )

  18. Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Dendritic Spine Maturation and Morphogenesis via MicroRNA-132 Upregulation. 2019.05; 39 (22): 4208-4220. ( PubMed, DOI )

  19. Whole-brain block-face serial microscopy tomography at subcellular resolution using FAST. 2019.05; 14 (5): 1509-1529. ( PubMed, DOI )

  20. Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism 2018.03; 19 (3): ( PubMed, DOI )

  21. Shintani Y, Hayata-Takano A, Moriguchi K, Nakazawa T, Ago Y, Kasai A, Seiriki K, Shintani N, Hashimoto H. β-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking. PloS one. 2018; 13 (5): e0196946. ( PubMed, DOI )

  22. High-Speed and Scalable Whole-Brain Imaging in Rodents and Primates 2017.06; 94 (6): 1085-+. ( PubMed, DOI )

▼display all

To the head of this page.▲

Awards & Honors 【 display / non-display 】

  • 年会優秀発表賞，2017.03

To the head of this page.▲
 

External class subject 【 display / non-display 】

  • Pharmacology，The University of Osaka

  • Practical Course in Basic Pharmacology，The University of Osaka

To the head of this page.▲